This chemical is primarily utilized in the synthesis of pharmaceutical compounds, particularly those targeting inflammatory and autoimmune conditions. It serves as a key intermediate in the production of PDE4 inhibitors, which are effective in treating diseases like psoriasis, chronic obstructive pulmonary disease (COPD), and asthma. Its structural properties make it suitable for enhancing the selectivity and potency of these drugs. Additionally, it is employed in research and development to explore new therapeutic agents, leveraging its imidazolidinone core for innovative drug design.